BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 17490783)

  • 1. Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001-2005.
    Goldberg MS; Doucette JT; Lim HW; Spencer J; Carucci JA; Rigel DS
    J Am Acad Dermatol; 2007 Jul; 57(1):60-6. PubMed ID: 17490783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for improving melanoma education and screening for men age >or= 50 years: findings from the American Academy of Dermatological National Skin Cancer Sreening Program.
    Geller AC; Sober AJ; Zhang Z; Brooks DR; Miller DR; Halpern A; Gilchrest BA
    Cancer; 2002 Oct; 95(7):1554-61. PubMed ID: 12237925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive predictive value for presumptive diagnoses of skin cancer and compliance with follow-up among patients attending a community screening program.
    Jonna BP; Delfino RJ; Newman WG; Tope WD
    Prev Med; 1998; 27(4):611-6. PubMed ID: 9672956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of factors associated with skin self-examination.
    Oliveria SA; Christos PJ; Halpern AC; Fine JA; Barnhill RL; Berwick M
    Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):971-8. PubMed ID: 10566551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case-control study to identify melanoma risk factors in the Belgian population: the significance of clinical examination.
    Nijsten T; Leys C; Verbruggen K; Verlinden V; Drieghe J; Stas M; Lambert J; DeGreef H; Garmyn M
    J Eur Acad Dermatol Venereol; 2005 May; 19(3):332-9. PubMed ID: 15857460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased melanoma risk in Parkinson disease: a prospective clinicopathological study.
    Bertoni JM; Arlette JP; Fernandez HH; Fitzer-Attas C; Frei K; Hassan MN; Isaacson SH; Lew MF; Molho E; Ondo WG; Phillips TJ; Singer C; Sutton JP; Wolf JE;
    Arch Neurol; 2010 Mar; 67(3):347-52. PubMed ID: 20212233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999.
    Geller AC; Zhang Z; Sober AJ; Halpern AC; Weinstock MA; Daniels S; Miller DR; Demierre MF; Brooks DR; Gilchrest BA
    J Am Acad Dermatol; 2003 Jan; 48(1):34-41. PubMed ID: 12522368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatologist detection and skin self-examination are associated with thinner melanomas: results from a survey of the Italian Multidisciplinary Group on Melanoma.
    Carli P; De Giorgi V; Palli D; Maurichi A; Mulas P; Orlandi C; Imberti GL; Stanganelli I; Soma P; Dioguardi D; Catricalá C; Betti R; Cecchi R; Bottoni U; Bonci A; Scalvenzi M; Giannotti B;
    Arch Dermatol; 2003 May; 139(5):607-12. PubMed ID: 12756097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing melanoma risk factors: how closely do patients and doctors agree?
    Richtig E; Santigli E; Fink-Puches R; Weger W; Hofmann-Wellenhof R
    Public Health; 2008 Dec; 122(12):1433-9. PubMed ID: 18752818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the usefulness of self-reported risk factors in a skin cancer screening program.
    Williams HA; Fritschi L; Beauchamp C; Katris P
    Melanoma Res; 2006 Aug; 16(4):341-5. PubMed ID: 16845330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What motivates men age > or =50 years to participate in a screening program for melanoma?
    Janda M; Youl PH; Lowe JB; Baade PD; Elwood M; Ring IT; Aitken JF
    Cancer; 2006 Aug; 107(4):815-23. PubMed ID: 16832794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes from skin screening clinics within a community-based melanoma screening program.
    Aitken JF; Janda M; Elwood M; Youl PH; Ring IT; Lowe JB
    J Am Acad Dermatol; 2006 Jan; 54(1):105-14. PubMed ID: 16384764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial to improve early detection and prevention practices among siblings of melanoma patients.
    Geller AC; Emmons KM; Brooks DR; Powers C; Zhang Z; Koh HK; Heeren T; Sober AJ; Li F; Gilchrest BA
    Cancer; 2006 Aug; 107(4):806-14. PubMed ID: 16832795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Skin cancer screening program in the population of Bydgoszcz].
    Mierzwa T; Zegarski W; Placek W; Zegarska B
    Wiad Lek; 2004; 57 Suppl 1():211-4. PubMed ID: 15884241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who attends skin cancer clinics within a randomized melanoma screening program?
    Youl PH; Janda M; Elwood M; Lowe JB; Ring IT; Aitken JF
    Cancer Detect Prev; 2006; 30(1):44-51. PubMed ID: 16457967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of skin cancer screening for individuals age 14 to 34 years.
    Schmitt J; Seidler A; Heinisch G; Sebastian G
    J Dtsch Dermatol Ges; 2011 Aug; 9(8):608-16. PubMed ID: 21501381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survey of knowledge of and awareness about melanoma--United States, 1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 May; 45(17):346-9. PubMed ID: 8604211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma: prevention and early detection.
    Bordeaux JS; Lu KQ; Cooper KD
    Semin Oncol; 2007 Dec; 34(6):460-6. PubMed ID: 18083369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tanning bed exposure increases the risk of malignant melanoma.
    Ting W; Schultz K; Cac NN; Peterson M; Walling HW
    Int J Dermatol; 2007 Dec; 46(12):1253-7. PubMed ID: 18173518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing participation in cutaneous screening among individuals with a family history of melanoma.
    Azzarello LM; Jacobsen PB
    J Am Acad Dermatol; 2007 Mar; 56(3):398-406. PubMed ID: 17184873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.